Novel Alexa Fluor-488 labeled antagonist of the A2A adenosine receptor: Application to a fluorescence polarization-based receptor binding assay
- 15 August 2010
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 80 (4), 506-511
- https://doi.org/10.1016/j.bcp.2010.04.027
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A Fluorescence Anisotropy Assay for the Muscarinic M1 G-protein-Coupled ReceptorASSAY and Drug Development Technologies, 2010
- Functionalized Congeners of A3 Adenosine Receptor-Selective Nucleosides Containing a Bicyclo[3.1.0]hexane Ring SystemJournal of Medicinal Chemistry, 2009
- Functionalized Congener Approach to the Design of Ligands for G Protein-Coupled Receptors (GPCRs)Bioconjugate Chemistry, 2009
- Design, Synthesis, and Pharmacology of Fluorescently Labeled Analogs of Serotonin: Application to Screening of the 5-HT2C ReceptorSLAS Discovery, 2009
- The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an AntagonistScience, 2008
- Enhanced A3 adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugatesJournal of Nanobiotechnology, 2008
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseasesNature Reviews Drug Discovery, 2008
- 2-[2-[4-[2-[2-[1,3-Dihydro-1,1-bis(4-hydroxyphenyl)-3-oxo-5-isobenzofuranthioureidyl]ethylaminocarbonyl]ethyl]phenyl] ethylamino]-5?-N-ethylcarboxamidoadenosine (FITC-APEC): A fluorescent ligand for A2a-adenosine receptorsJournal of Fluorescence, 1992
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973